Related Experiment Video
Updated: Mar 29, 2026
12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
7.0K
Anti-inflammatory and anti-oxidant properties: Is there a link?
I Kh Valeeva1, A F Titarenko2, V N Khaziakhmetova2
1Kazan State Medical University, Central Research Laboratory, Kazan, Russia.
The International Journal of Risk & Safety in Medicine
|December 8, 2015
Summary
This study investigated new anti-inflammatory drugs in rats with adjuvant arthritis, finding inconsistent links between antioxidant and anti-inflammatory effects. Further research is needed before clinical application.
Area of Science:
- Pharmacology and Toxicology
- Inflammation Research
- Oxidative Stress Studies
Background:
- Clinical evidence for antioxidant effects on inflammatory disorders is limited, despite theoretical links between antioxidant and anti-inflammatory activities.
- This study addresses the gap by evaluating novel pharmacological agents in an experimental arthritis model.
Purpose of the Study:
- To assess the anti-inflammatory and antioxidant properties of dimephosphone, ephorane, mephoprane, and xymedon.
- To compare these agents with established drugs, prednisolone and etidronate, in a rat model of adjuvant arthritis.
Main Methods:
- Adjuvant arthritis was induced in 64 rats, divided into 8 groups, including controls and treatment groups.
- Paw volume was measured to assess inflammation, and blood markers of oxidative stress (catalase, glutathione, lipid peroxidation products) were analyzed.
Main Results:
- Dimephosphone, ephorane, and prednisolone demonstrated anti-inflammatory effects, reducing paw swelling.
- Dimephosphone and ephorane exhibited antioxidant activity by reducing lipid peroxidation and increasing glutathione levels.
- Mephoprane reduced secondary arthritis but lacked antioxidant effects; xymedon showed antioxidant properties without anti-inflammatory effects; etidronate acted as a pro-oxidant.
Conclusions:
- The anti-inflammatory and antioxidant effects of the studied agents were inconsistent.
- A clear correlation between anti-inflammatory and antioxidant activities was not established in this model.
- Further investigation is required to determine the clinical utility of novel drugs with antioxidant properties for inflammatory conditions.
Related Concept Videos
01:28Inflammatory Response
18.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
18.9K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
613
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
613
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
664
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
664
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
01:20Radical Autoxidation
3.4K
The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
3.4K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
740
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
740